Skip to content

Preview

The past 50 years of innovation were about the byte. We think the future will be about the atom and the gene. Our focus in this paper is the atom, specifically how advances in production may alter the physical world—transforming cars, robots, drones, medical devices and drugs and creating new modalities never considered before. These products will be variable and complex and upend the manufacturing status quo. With this shift in mind, we make the case that the new heroes in business will be producers. We try to break the myth that production is unprofitable, commoditized and largely not investable. In this paper, you will find three business models selected to show production as an engine for long-term profitability and value creation: technological competitive advantage, scaled economies shared and personalization.

Key takeaways:

  • In the Fourth Industrial Revolution, production will play a key role. New technologies will disrupt current ones, creating new winners. The general-purpose technologies we have identified so far include electric vehicles, clean energy, artificial intelligence, robotics, and genomics.
  • We are already seeing production gain in importance in the case of the big tech companies, who were once asset-light and are now spending heavily on capital expenditures.
  • The skillsets are different for inventors and producers. A successful innovation requires both.

This is an optimistic time—that technological progress compounds on itself has never been more apparent. Yet, if the digital revolution was a disappearing act, where the world dissolved into the computer, the wonders of this next era will spill back out of the machine, coming to transform our physical world. We have always needed both dreamers and producers, but the stories of innovation have tended to favor the former. Now, the pendulum of history is shifting toward the Boschs, Cooks and Changs—those talented individuals who take inventions out of the lab and into the world.



IMPORTANT LEGAL INFORMATION

This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice.

The views expressed are those of the investment manager and the comments, opinions and analyses are rendered as at publication date and may change without notice. The information provided in this material is not intended as a complete analysis of every material fact regarding any country, region or market. All investments involve risks, including possible loss of principal.

Data from third party sources may have been used in the preparation of this material and Franklin Templeton ("FT") has not independently verified, validated or audited such data. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments opinions and analyses in the material is at the sole discretion of the user.

Products, services and information may not be available in all jurisdictions and are offered outside the U.S. by other FT affiliates and/or their distributors as local laws and regulation permits. Please consult your own financial professional or Franklin Templeton institutional contact for further information on availability of products and services in your jurisdiction.

Issued by Franklin Templeton Investment Management Limited (FTIML). Registered office: Cannon Place, 78 Cannon Street, London EC4N 6HL. FTIML is authorised and regulated by the Financial Conduct Authority.

Investments entail risks, the value of investments can go down as well as up and investors should be aware they might not get back the full value invested.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.